Aligos Therapeutics is based out of South San Francisco. Aligos Therapeutics, Inc. is a clinical stage biopharmaceutical company that was founded in 2018 with the mission to become a world leader in the treatment of viral infections and liver diseases. ligos��� strategy is to harness the deep expertise and decades of drug development experience its workforce has in liver disease, particularly viral hepatitis, to rapidly advance its pipeline of potentially best-in-class molecules. The firm last filed a Form D notice of exempt offering of securities on 2023-11-07. The notice included securities offered of Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security
Contact Info
Contact information is taken directly from publicly disclosed SEC filings.
Aligos Therapeutics, Inc.ONE CORPORATE DR., 2ND FLOOR
SOUTH SAN FRANCISCO CA 94080
Business Phone: (800) 466-6059
SEC SIC CODE:
2836-BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
2836-BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)